id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_vtg2ikp7wfcwzhwdrbtddjdflq	Michael Miller	Apolipoprotein C-III	2017.0	2	.pdf	application/pdf	1921	240	58	(including R19X) were subsequently found to have low triglyceride and a significantly reduced risk of vascular disease.14,15 In contrast, studies examining the effect of apoC-III enrichment in apoB containing lipoproteins (ie, very low-density lipoprotein and LDL) identified increased coronary arteriographic adjustment for triglyceride.18 In the second study, apoC-III levels in the top quartile at baseline were predictive of cardiovascular death over the 15-year follow-up period.19 However, this The study by van Capelleveen et al4 confirms the association between plasma apoC-III levels and incident CAD. Although these effects were attenuated after adjustment for triglyceride, subgroup analysis found apoC-III to remain independently associated with CAD in subjects with high triglyceride Interestingly, the combination of high triglyceride and low apoC-III was not associated apoC-III may potentiate vascular risk, especially in the setting © 2017 American Heart Association, Inc. Arterioscler Thromb Vasc Biol is available at http://atvb.ahajournals.org lipoproteins containing apolipoprotein C-III and the risk of coronary heart 	./cache/work_vtg2ikp7wfcwzhwdrbtddjdflq.pdf	./txt/work_vtg2ikp7wfcwzhwdrbtddjdflq.txt